EBS
Price
$7.58
Change
-$0.05 (-0.66%)
Updated
Sep 5 closing price
Capitalization
404.4M
59 days until earnings call
RMTI
Price
$1.62
Change
-$0.06 (-3.57%)
Updated
Sep 5 closing price
Capitalization
55.78M
71 days until earnings call
Interact to see
Advertisement

EBS vs RMTI

Header iconEBS vs RMTI Comparison
Open Charts EBS vs RMTIBanner chart's image
Emergent Biosolutions
Price$7.58
Change-$0.05 (-0.66%)
Volume$830.96K
Capitalization404.4M
Rockwell Medical
Price$1.62
Change-$0.06 (-3.57%)
Volume$1.91M
Capitalization55.78M
EBS vs RMTI Comparison Chart in %
Loading...
EBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RMTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EBS vs. RMTI commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EBS is a Buy and RMTI is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (EBS: $7.58 vs. RMTI: $1.62)
Brand notoriety: EBS and RMTI are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: EBS: 69% vs. RMTI: 146%
Market capitalization -- EBS: $404.4M vs. RMTI: $55.78M
EBS [@Pharmaceuticals: Generic] is valued at $404.4M. RMTI’s [@Pharmaceuticals: Generic] market capitalization is $55.78M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EBS’s FA Score shows that 1 FA rating(s) are green whileRMTI’s FA Score has 0 green FA rating(s).

  • EBS’s FA Score: 1 green, 4 red.
  • RMTI’s FA Score: 0 green, 5 red.
According to our system of comparison, EBS is a better buy in the long-term than RMTI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EBS’s TA Score shows that 7 TA indicator(s) are bullish while RMTI’s TA Score has 6 bullish TA indicator(s).

  • EBS’s TA Score: 7 bullish, 4 bearish.
  • RMTI’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, EBS is a better buy in the short-term than RMTI.

Price Growth

EBS (@Pharmaceuticals: Generic) experienced а -8.67% price change this week, while RMTI (@Pharmaceuticals: Generic) price change was -5.26% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Reported Earning Dates

EBS is expected to report earnings on Nov 05, 2025.

RMTI is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EBS($404M) has a higher market cap than RMTI($55.8M). RMTI (-20.588) and EBS (-20.711) have similar YTD gains . EBS has higher annual earnings (EBITDA): 344M vs. RMTI (1.23M). EBS has more cash in the bank: 267M vs. RMTI (18.4M). RMTI has less debt than EBS: RMTI (14M) vs EBS (668M). EBS has higher revenues than RMTI: EBS (812M) vs RMTI (88M).
EBSRMTIEBS / RMTI
Capitalization404M55.8M724%
EBITDA344M1.23M27,899%
Gain YTD-20.711-20.588101%
P/E Ratio2.89N/A-
Revenue812M88M923%
Total Cash267M18.4M1,451%
Total Debt668M14M4,771%
FUNDAMENTALS RATINGS
EBS vs RMTI: Fundamental Ratings
EBS
RMTI
OUTLOOK RATING
1..100
7428
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
47
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
3295
PRICE GROWTH RATING
1..100
4238
P/E GROWTH RATING
1..100
64100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RMTI's Valuation (47) in the Medical Specialties industry is in the same range as EBS (54) in the Biotechnology industry. This means that RMTI’s stock grew similarly to EBS’s over the last 12 months.

RMTI's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as EBS (100) in the Biotechnology industry. This means that RMTI’s stock grew similarly to EBS’s over the last 12 months.

EBS's SMR Rating (32) in the Biotechnology industry is somewhat better than the same rating for RMTI (95) in the Medical Specialties industry. This means that EBS’s stock grew somewhat faster than RMTI’s over the last 12 months.

RMTI's Price Growth Rating (38) in the Medical Specialties industry is in the same range as EBS (42) in the Biotechnology industry. This means that RMTI’s stock grew similarly to EBS’s over the last 12 months.

EBS's P/E Growth Rating (64) in the Biotechnology industry is somewhat better than the same rating for RMTI (100) in the Medical Specialties industry. This means that EBS’s stock grew somewhat faster than RMTI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EBSRMTI
RSI
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
89%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 18 days ago
76%
Bullish Trend 11 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
EBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RMTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KAKKF14.45N/A
N/A
Kawasaki Kisen Kaisha, Ltd.
BCCOY0.56N/A
N/A
BICO GROUP AB
BKFAF7.01N/A
N/A
BROOKFIELD CORP.
NICMF0.46N/A
N/A
Nickel Industries Ltd
TAOIF0.09N/A
-0.44%
TAG Oil Ltd.

EBS and

Correlation & Price change

A.I.dvisor indicates that over the last year, EBS has been loosely correlated with SIGA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if EBS jumps, then SIGA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EBS
1D Price
Change %
EBS100%
-0.66%
SIGA - EBS
43%
Loosely correlated
-0.82%
VTRS - EBS
42%
Loosely correlated
+1.65%
ELAN - EBS
39%
Loosely correlated
+5.50%
HKMPF - EBS
34%
Loosely correlated
N/A
PAHC - EBS
33%
Poorly correlated
+0.97%
More

RMTI and

Correlation & Price change

A.I.dvisor tells us that RMTI and AVDL have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RMTI and AVDL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMTI
1D Price
Change %
RMTI100%
-3.57%
AVDL - RMTI
33%
Poorly correlated
+5.14%
EVOK - RMTI
28%
Poorly correlated
-1.51%
HROW - RMTI
28%
Poorly correlated
+2.18%
AKBA - RMTI
27%
Poorly correlated
-1.99%
EBS - RMTI
27%
Poorly correlated
-0.66%
More